Health ❯ Healthcare ❯ Chronic Diseases

Inflammatory Bowel Disease

Ulcerative Colitis Crohn's Disease Epithelial Dysfunction Moderate-to-Severe Crohn's Disease Atopic Dermatitis Bioelectric Mechanisms Sleep Disorders

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

Full safety data plus the FDA review will decide whether the clustered malignancy observations change labeling or approval prospects.

Preclinical Study Finds Low-Dose Cancer Drugs Restore Gut Barrier in Crohn’s Models

Merck and Mayo Clinic Launch AI Drug Discovery Collaboration Using Platform_Orchestrate

Time-Restricted Eating Cuts Crohn’s Disease Activity 40% in 12-Week Trial

AGA Overhauls Crohn’s Treatment With Living Guideline Favoring Early High‑Efficacy Therapies

Abivax’s Obefazimod Meets Phase 3 Week-8 Remission Goals in Ulcerative Colitis